[{"NetIncomeLoss_1_Q2_USD":-11632000.0,"OperatingLeaseLiability_0_Q2_USD":10245000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6269000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3268000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":2420797.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":2625648.0,"AccruedLiabilitiesCurrent_0_Q2_USD":4546000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":110000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":38844000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":53683.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":1000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-134000.0,"AssetsCurrent_0_Q2_USD":107288000.0,"OperatingLeaseExpense_1_Q2_USD":1000000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":26156000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":59398350.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":173127000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":542000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3600000.0,"CommonStockSharesIssued_0_Q2_shares":6559348.0,"Assets_0_Q2_USD":117846000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":42000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-134000.0,"ShareBasedCompensation_2_Q2_USD":1138000.0,"OperatingLeaseExpense_2_Q2_USD":2000000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10245000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":42000.0,"Liabilities_0_Q2_USD":16013000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1800000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":15724000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":8885000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":3.82,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":11100000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":65000000.0,"TemporaryEquityLiquidationPreference_0_Q2_USD":188034000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":79398350.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q2_shares":39859139.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":399000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":355000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":98643.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.895,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-271000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":37000.0,"TemporaryEquitySharesIssued_0_Q2_shares":59398350.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":104500000.0,"PreferredStockDividendRatePercentage_2_Q2_pure":0.08,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-20929000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-11766000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":972000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0048,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":78267000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":7098000.0,"GrantsReceivableCurrent_0_Q2_USD":354000.0,"ShortTermInvestments_0_Q2_USD":26184000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":44091210.0,"InterestReceivableCurrent_0_Q2_USD":58000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-76290000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":17183000.0,"CommonStockSharesOutstanding_0_Q2_shares":2801859.0,"IncreaseDecreaseInAccruedInterestReceivableNet_2_Q2_USD":-204000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":118000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":492000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-21661000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3600000.0,"LiabilitiesCurrent_0_Q2_USD":8915000.0,"ManagementFeeExpense_1_Q2_USD":100000.0,"AccountsPayableCurrent_0_Q2_USD":680000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":73134000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":42000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0514,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-20971000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-11632000.0,"AdditionalPaidInCapital_0_Q2_USD":4886000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":78267000.0,"OperatingLeasePayments_2_Q2_USD":2400000.0,"OperatingLeasePayments_1_Q2_USD":1200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":313000.0,"NetIncomeLoss_2_Q2_USD":-20971000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2425000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ManagementFeeExpense_2_Q2_USD":400000.0,"StockholdersEquity_0_Q2_USD":-71294000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":3.3,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":3.38,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":855000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1749000.0,"CommonStockSharesAuthorized_0_Q2_shares":90000000.0,"OperatingIncomeLoss_2_Q2_USD":-21993000.0,"OperatingIncomeLoss_1_Q2_USD":-12153000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":26184000.0,"InvestmentIncomeInterest_2_Q2_USD":623000.0,"InvestmentIncomeInterest_1_Q2_USD":166000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.5,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":26067000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":117846000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1138000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":492000.0,"SharePrice_0_Q2_USD":4.6,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3147000.0,"OperatingExpenses_2_Q2_USD":21993000.0,"OperatingExpenses_1_Q2_USD":12153000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-8.66,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-4.43,"ProfitLoss_2_Q2_USD":-20971000.0,"DeferredOfferingCosts_0_Q2_USD":1300000.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":770000.0,"Ticker":"ALVR","CIK":"1754068","name":"ALLOVIR, INC.","OfficialName":"AlloVir Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"339041308.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200902"}]